Current and Future Applications of Local Field Potential-guided Programming for Parkinson's Disease with the Percept™ Rechargeable Neurostimulator

Overview

Journal Neurodegener Dis Manag

Date 2024 Sep 30

PMID 39344591

Authors

Weerawat Saengphatrachai

Joohi Jimenez-Shahed

Affiliations

Soon will be listed here.

Abstract

Deep brain stimulation (DBS) has been established as an effective neuromodulatory treatment for Parkinson's disease (PD) with motor complications or refractory tremor. Various DBS devices with unique technology platforms are commercially available and deliver continuous, open-loop stimulation. The Percept™ family of neurostimulators use BrainSense™ technology with five key features to sense local field potentials while stimulating, enabling integration of physiologic data into the routine practice of DBS programming. The newly approved Percept™ rechargeable RC implantable pulse generator offers a smaller, thinner design and reduced recharge time with prolonged recharge interval. In this review, we describe the application of local field potential sensing-based programming in PD and highlight the potential future clinical implementation of closed-loop stimulation using the Percept™ RC implantable pulse generator.

References

Marceglia S, Conti C, Svanidze O, Foffani G, Lozano A, Moro E . Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinson's disease. BMJ Open. 2022; 12(1):e049955. PMC: 8724732. DOI: 10.1136/bmjopen-2021-049955. View

Kuhn A, Kupsch A, Schneider G, Brown P . Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease. Eur J Neurosci. 2006; 23(7):1956-60. DOI: 10.1111/j.1460-9568.2006.04717.x. View

Stanslaski S, Summers R, Tonder L, Tan Y, Case M, Raike R . Sensing data and methodology from the Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) clinical trial. NPJ Parkinsons Dis. 2024; 10(1):174. PMC: 11408616. DOI: 10.1038/s41531-024-00772-5. View

Wiest C, Tinkhauser G, Pogosyan A, Bange M, Muthuraman M, Groppa S . Local field potential activity dynamics in response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Neurobiol Dis. 2020; 143:105019. PMC: 7115855. DOI: 10.1016/j.nbd.2020.105019. View

van Wijk B, Beudel M, Jha A, Oswal A, Foltynie T, Hariz M . Subthalamic nucleus phase-amplitude coupling correlates with motor impairment in Parkinson's disease. Clin Neurophysiol. 2016; 127(4):2010-9. PMC: 4803022. DOI: 10.1016/j.clinph.2016.01.015. View

Wagle Shukla A, Zeilman P, Fernandez H, Bajwa J, Mehanna R . DBS Programming: An Evolving Approach for Patients with Parkinson's Disease. Parkinsons Dis. 2017; 2017:8492619. PMC: 5632902. DOI: 10.1155/2017/8492619. View

Weinberger M, Hutchison W, Alavi M, Hodaie M, Lozano A, Moro E . Oscillatory activity in the globus pallidus internus: comparison between Parkinson's disease and dystonia. Clin Neurophysiol. 2011; 123(2):358-68. DOI: 10.1016/j.clinph.2011.07.029. View

Meidahl A, Tinkhauser G, Herz D, Cagnan H, Debarros J, Brown P . Adaptive Deep Brain Stimulation for Movement Disorders: The Long Road to Clinical Therapy. Mov Disord. 2017; 32(6):810-819. PMC: 5482397. DOI: 10.1002/mds.27022. View

Little S, Tripoliti E, Beudel M, Pogosyan A, Cagnan H, Herz D . Adaptive deep brain stimulation for Parkinson's disease demonstrates reduced speech side effects compared to conventional stimulation in the acute setting. J Neurol Neurosurg Psychiatry. 2016; 87(12):1388-1389. PMC: 5136720. DOI: 10.1136/jnnp-2016-313518. View

10.

Mahajan A, Butala A, Okun M, Mari Z, Mills K . Global Variability in Deep Brain Stimulation Practices for Parkinson's Disease. Front Hum Neurosci. 2021; 15:667035. PMC: 8044366. DOI: 10.3389/fnhum.2021.667035. View

11.

Yang A, Vanegas N, Lungu C, Zaghloul K . Beta-coupled high-frequency activity and beta-locked neuronal spiking in the subthalamic nucleus of Parkinson's disease. J Neurosci. 2014; 34(38):12816-27. PMC: 4166162. DOI: 10.1523/JNEUROSCI.1895-14.2014. View

12.

Ray N, Jenkinson N, Wang S, Holland P, Brittain J, Joint C . Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation. Exp Neurol. 2008; 213(1):108-13. DOI: 10.1016/j.expneurol.2008.05.008. View

13.

Nguyen T, Djilas M, Nowacki A, Mercanzini A, Schupbach M, Renaud P . Analysis of patient-specific stimulation with segmented leads in the subthalamic nucleus. PLoS One. 2019; 14(6):e0217985. PMC: 6584006. DOI: 10.1371/journal.pone.0217985. View

14.

van Rheede J, Feldmann L, Busch J, Fleming J, Mathiopoulou V, Denison T . Diurnal modulation of subthalamic beta oscillatory power in Parkinson's disease patients during deep brain stimulation. NPJ Parkinsons Dis. 2022; 8(1):88. PMC: 9270436. DOI: 10.1038/s41531-022-00350-7. View

15.

Jia F, Wagle Shukla A, Hu W, Almeida L, Holanda V, Zhang J . Deep Brain Stimulation at Variable Frequency to Improve Motor Outcomes in Parkinson's Disease. Mov Disord Clin Pract. 2019; 5(5):538-541. PMC: 6207106. DOI: 10.1002/mdc3.12658. View

16.

Jost S, Aloui S, Evans J, Ashkan K, Sauerbier A, Rizos A . Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years: A Nonrandomized Controlled Trial. JAMA Netw Open. 2024; 7(1):e2352177. PMC: 10797423. DOI: 10.1001/jamanetworkopen.2023.52177. View

17.

Alagapan S, Choi K, Heisig S, Riva-Posse P, Crowell A, Tiruvadi V . Cingulate dynamics track depression recovery with deep brain stimulation. Nature. 2023; 622(7981):130-138. PMC: 10550829. DOI: 10.1038/s41586-023-06541-3. View

18.

Sarica C, Iorio-Morin C, Aguirre-Padilla D, Najjar A, Paff M, Fomenko A . Implantable Pulse Generators for Deep Brain Stimulation: Challenges, Complications, and Strategies for Practicality and Longevity. Front Hum Neurosci. 2021; 15:708481. PMC: 8427803. DOI: 10.3389/fnhum.2021.708481. View

19.

Anderson R, Wilkins K, Parker J, Petrucci M, Kehnemouyi Y, Neuville R . Lack of progression of beta dynamics after long-term subthalamic neurostimulation. Ann Clin Transl Neurol. 2021; 8(11):2110-2120. PMC: 8607445. DOI: 10.1002/acn3.51463. View

20.

Okun M, Gallo B, Mandybur G, Jagid J, Foote K, Revilla F . Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. Lancet Neurol. 2012; 11(2):140-9. DOI: 10.1016/S1474-4422(11)70308-8. View